Actos - New FDA Warnings For Actos Labels
Actos, a prescription medication manufactured by Takeda and prescribed for the treatment of type 2 diabetes has received approval from the FDA for new updated warning labels.
The new Actos warning label has been updated to state Actos usage for more than one year may cause bladder cancer. Actos has been stated as under review by the Food and Drug Administration since 2010.
In response to a growing number of bladder cancer claims, drug regulation agencies in Germany and France have suspended use of Actos while the FDA only issued warnings.
Similar drugs Actoplus Met, Actoplus Met, and XR, Duetact may also be linked to bladder cancer and are currently being investigated by multiple parties.
More on Actos damaging side effects and known medical problems.... ...read full post
The new Actos warning label has been updated to state Actos usage for more than one year may cause bladder cancer. Actos has been stated as under review by the Food and Drug Administration since 2010.
In response to a growing number of bladder cancer claims, drug regulation agencies in Germany and France have suspended use of Actos while the FDA only issued warnings.
Similar drugs Actoplus Met, Actoplus Met, and XR, Duetact may also be linked to bladder cancer and are currently being investigated by multiple parties.
More on Actos damaging side effects and known medical problems.... ...read full post
